Dennis Mulroy's Net Worth
$238 Thousand
Who is Dennis Mulroy?
Dennis Mulroy does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ANAPTYSBIO, INC, Cardium Therapeutics, Inc., LA JOLLA PHARMACEUTICAL CO, and MOLECULAR IMAGING CORP.
SEC CIK
Dennis Mulroy's CIK is 0001276840
Past Insider Trading and Trends
2019 was Dennis Mulroy's most active year for acquiring shares with 49 total transactions. Dennis Mulroy's most active month to acquire stocks was the month of December. 2024 was Dennis Mulroy's most active year for disposing of shares, totalling 4 transactions. Dennis Mulroy's most active month to dispose stocks was the month of December. 2005 saw Dennis Mulroy paying a total of $720,750,000.00 for 430,000 shares, this is the most they've acquired in one year. In 2023 Dennis Mulroy cashed out on 12,000 shares for a total of $116,242.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANAPTYSBIO, INC (ANAB) Snapshot price: $35.9
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +392.12% | 3.78K |
$30.03 | -$487,724.60 | 4.74K |
Scheduled
|
Sep 14 - Sep 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
| -60.88% | -1.50K |
$23.72 | -$35,580.00 | 964 |
Scheduled
|
May 22
| ||
Form 4
| -76.07% | -3.06K |
$23.63 | -$72,425.34 | 964 |
Jan 30
| |||
Form 4
| +317.95% | 3.06K |
$21.81 | -$47,545.80 | 4.03K |
Jan 6 - Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
$19.37 | -$116,242.00 | 964 |
Sep 14 - Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
∞
| 964 |
$22.03 | $21,236.92 | 964 |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cardium Therapeutics, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LA JOLLA PHARMACEUTICAL CO No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.64% | 82 |
$4.01 | $328.82 | 5.07K |
May 29
| |||
Form 4
| +1.14% | 56 |
$5.86 | $328.16 | 4.99K |
May 15
| |||
Form 4
| +1.09% | 53 |
$6.17 | $327.01 | 4.93K |
Apr 30
| |||
Form 4
| +1.20% | 58 |
$5.61 | $325.38 | 4.88K |
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
| +0.33% | 16 |
$3.34 | $53.44 | 4.82K |
Dec 31
| |||
Form 4
| +2.39% | 112 |
$2.85 | $319.20 | 4.8K |
Dec 13
| |||
Form 4
| +3.03% | 138 |
$2.33 | $321.54 | 4.69K |
Nov 29
| |||
Form 4
| +1.38% | 62 |
$5.12 | $317.44 | 4.55K |
Nov 15
| |||
Form 4
| +6.32% | 267 |
$5.96 | $1,591.32 | 4.49K |
Oct 31
| |||
Form 4
| +5.60% | 224 |
$7.12 | $1,594.88 | 4.22K |
Oct 15
| |||
Form 4
| +5.63% | 213 |
$7.48 | $1,593.24 | 4K |
Sep 30
| |||
Form 4
| +4.73% | 171 |
$9.28 | $1,586.88 | 3.79K |
Sep 13
| |||
Form 4
| +5.73% | 196 |
$8.13 | $1,593.48 | 3.62K |
Aug 30
| |||
Form 4
| +6.15% | 198 |
$8.02 | $1,587.96 | 3.42K |
Aug 15
| |||
Form 4
| +7.47% | 224 |
$7.11 | $1,592.64 | 3.22K |
Jul 31
| |||
Form 4
| +7.27% | 203 |
$7.85 | $1,593.55 | 3K |
Jul 15
| |||
Form 4
| +7.79% | 202 |
$7.86 | $1,587.72 | 2.79K |
Jun 28
| |||
Form 4
| +8.05% | 193 |
$8.25 | $1,592.25 | 2.59K |
Jun 14
| |||
Form 4
| +16.91% | 347 |
$4.58 | $1,589.26 | 2.4K |
May 31
| |||
Form 4
| +16.13% | 285 |
$5.58 | $1,590.30 | 2.05K |
May 15
| |||
Form 4
| +15.19% | 233 |
$6.84 | $1,593.72 | 1.77K |
Apr 30
| |||
Form 4
| +20.50% | 261 |
$6.09 | $1,589.49 | 1.53K |
Apr 15
| |||
Form 4
| +4.86% | 59 |
$5.47 | $322.73 | 1.27K |
Mar 29
| |||
Form 4
| +4.21% | 49 |
$6.49 | $318.01 | 1.21K |
Mar 15
| |||
Form 4
| +5.91% | 65 |
$4.85 | $315.25 | 1.17K |
Feb 28
| |||
Form 4
| +5.77% | 60 |
$5.30 | $318.00 | 1.1K |
Feb 15
| |||
Form 4
| +6.45% | 63 |
$5.13 | $323.19 | 1.04K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +47.81% | 316 |
$5.74 | $1,813.84 | 977 |
Jan 15
| |||
Form 4
| +6.27% | 39 |
$8.02 | $312.60 | 661 |
Dec 31
| |||
Form 4
| +4.71% | 28 |
$10.88 | $304.64 | 622 |
Dec 14
| |||
Form 4
| +4.58% | 26 |
$12.30 | $319.79 | 594 |
Nov 30
| |||
Form 4
| +4.41% | 24 |
$12.67 | $303.96 | 568 |
Nov 15
| |||
Form 4
| +4.21% | 22 |
$13.86 | $304.81 | 544 |
Oct 31
| |||
Form 4
| +4.40% | 22 |
$13.81 | $303.82 | 522 |
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
∞
| 500 |
$33.95 | $16,975.00 | 500 |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MOLECULAR IMAGING CORP No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||